Mutation frequencies and AID activation state in B-cell lymphomas from Ung-deficient mice

Oncogene

Volumn 24, Issue 18, 2005, Pages 3063-3066

  Nilsen, Hilde ^a,b   An, Qian ^a,b   Lindahl, Tomas ^a  

^a London Research Institute   (United Kingdom)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Aid; Bcl 6; c Myc; Ung

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD19 ANTIGEN; COMPLEMENTARY DNA; DNA GLYCOSYLTRANSFERASE; INTERLEUKIN 4; MESSENGER RNA; MYC PROTEIN; PROTEIN BCL 6; PROTEIN P53; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CYTIDINE DEAMINASE;

AGING; AID GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CONTROLLED STUDY; GENE; GENE ACTIVATION; GENE EXPRESSION; HISTOPATHOLOGY; LYMPH NODE; LYMPHOCYTE CULTURE; MISSENSE MUTATION; MITOGENESIS; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOMATIC HYPERMUTATION; SPLEEN; TRANSGENIC MOUSE; ANIMAL; GENETICS; METABOLISM;

ANIMALS; CYTIDINE DEAMINASE; LYMPHOMA, B-CELL; MICE; RNA, MESSENGER;

EID: 18344375547     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208480     Document Type: Article

References (15)

1. Barnes DE and Lindahl T. (2004). Anna. Rev. Genet., 38, 445-476.
2. Coleman AE, Ried T and Janz S. (2000). Genes Chr. Cancer, 29, 70-74.
3. Gearhart PJ. (2003). Oncogens, 22, 5379-5380.
4. Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A and Durandy A. (2003). Nat. Immunol., 4, 1023-1028.
5. Martin A and Scharff MD. (2002). Proc. Natl. Acad. Sci. USA, 99, 12304-12308.
6. Muramatsu M, Kinoshita K, Fagarasan S, Tamada S, Shinkai Y and Honjo T. (2000). Cell, 102, 553-563.
7. Nilsen H, Rosewell I, Robins P, Skjelbred F, Andersen S, Slupphaug G, Daly G, Krokan HE, Lindahl T and Barnes DE. (2000). Mol. Cell, 5, 1059-1065.
8. Nilsen H, Stamp G, Andersen S, Hrivnak G, Krokan HE, Lindahl T and Barnes DE. (2003). Oncogene, 22, 5381-5386.
9. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K and Honjo T. (2003). J. Exp. Med., 197, 1173-1181.
10. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RSK, Küppers R and Dalla-Favera R. (2001). Nature, 412, 341-346.
11. Pasqualucci L, Guglielmino R, Houldsworth J, Mohr J, Aoufouchi S, Polakiewicz R, Chaganti RSK and Dalla-Favera R. (2004). Blood, 104, 3318-3325.
12. Rada C, di Noia J and Neuberger MS. (2004). Mol. Cell, 16, 163-171.
13. Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T and Neuberger MS. (2002). Curr. Biol., 12, 1748-1755.
14. Revy P, Muto T, Levy Y, Geissman F, Plebani A, Sanai O, Catalan N, Forveille M, Duforque-Lagelouse R, Gennery A, Tezcan I, Ersoy F, Kayserilli H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A and Durandy A. (2000). Cell, 102, 565-575.
15. Rogozin IB and Kolchanov NA. (1992). Biochim. Biophys. Acta, 1171, 11-18.